Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai, China.
J Hematol Oncol. 2024 Aug 27;17(1):74. doi: 10.1186/s13045-024-01593-y.
Thyroid cancer (TC) is a significant global healthcare burden. However, the lack of comprehensive data has impeded our understanding of its global impact. We aimed to examine the burden of TC and its trends at the global, regional, and national levels using data stratified by sociodemographic index (SDI), sex, and age. Data on TC, including incidence, mortality, and disability-adjusted life-years (DALYs) from 1990 to 2021, were obtained from the Global Burden of Disease Study 2021. Estimated annual percentage changes (EAPCs) were calculated to assess the incidence rate, mortality, and DALYs trends. The incidence, mortality, and DALYs of TC in 2021 were 249,538 (95% uncertainty interval: 223,290-274,638), 44,799 (39,925-48,541), and 646,741 (599,119-717,357), respectively. The age-standardized incidence rate (ASIR) in 2021 was 2.914 (2.607-3.213), with an EAPC of 1.25 (1.14-1.37) compared to 1990. In 2021, the age-standardized death rate (ASDR) was 0.53 (0.47-0.575) and age-standardized DALYs rate was 14.571 (12.783-16.115). Compared with 1990, the EAPCs of ASDR and age-standardized DALYs rate showed decreasing trends, at - 0.24 (- 0.27 to - 0.21) and - 0.14 (- 0.17 to - 0.11), respectively. Low SDI regions showed the highest ASDR and age-standardized DALYs rate, at 0.642 (0.516-0.799) and 17.976 (14.18-23.06), respectively. Low-middle SDI regions had the highest EAPCs for ASDR and age-standardized DALYs rate, at 0.74 (0.71-0.78) and 0.67 (0.63-0.7), respectively. Females exhibited decreasing trend in ASDR and age-standardized DALYs rate, with EAPCs of - 0.58 (- 0.61 to - 0.55) and - 0.45 (- 0.47 to - 0.42), respectively. In contrast, males showed an increasing trend in ASDR and age-standardized DALYs rate, with EAPCs of 0.41 (0.35-0.46) for both. In high-income regions, most countries with decreased annual changes in deaths experience increasing age-related deaths. Over the past few decades, a notable increase in TC incidence and decreased mortality has been observed globally. Regions characterized by lower SDI, male sex, and an aging population exhibited no improvement in TC mortality. Effective resource allocation, meticulous control of risk factors, and tailored interventions are crucial for addressing these issues.
甲状腺癌(TC)是全球医疗保健的重大负担。然而,由于缺乏全面的数据,我们对其全球影响的了解受到了阻碍。我们旨在通过按社会人口指数(SDI)、性别和年龄分层的数据,研究全球、区域和国家层面 TC 的负担及其趋势。1990 年至 2021 年 TC 的发病率、死亡率和伤残调整生命年(DALYs)等数据来自全球疾病负担研究 2021 年。为评估发病率、死亡率和 DALYs 的趋势,计算了估计年度百分比变化(EAPC)。2021 年 TC 的发病率、死亡率和 DALYs 分别为 249538(95%不确定区间:223290-274638)、44799(39925-48541)和 646741(599119-717357)。2021 年年龄标准化发病率(ASIR)为 2.914(2.607-3.213),与 1990 年相比,EAPC 为 1.25(1.14-1.37)。2021 年年龄标准化死亡率(ASDR)为 0.53(0.47-0.575),年龄标准化 DALYs 率为 14.571(12.783-16.115)。与 1990 年相比,ASDR 和年龄标准化 DALYs 率的 EAPC 呈下降趋势,分别为-0.24(-0.27 至-0.21)和-0.14(-0.17 至-0.11)。SDI 较低的地区 ASDR 和年龄标准化 DALYs 率最高,分别为 0.642(0.516-0.799)和 17.976(14.18-23.06)。中低 SDI 地区的 ASDR 和年龄标准化 DALYs 率的 EAPC 最高,分别为 0.74(0.71-0.78)和 0.67(0.63-0.7)。女性的 ASDR 和年龄标准化 DALYs 率呈下降趋势,EAPC 分别为-0.58(-0.61 至-0.55)和-0.45(-0.47 至-0.42)。相比之下,男性的 ASDR 和年龄标准化 DALYs 率呈上升趋势,EAPC 均为 0.41(0.35-0.46)。在高收入地区,大多数死亡率年度变化下降的国家的与年龄相关的死亡人数都在增加。在过去几十年中,全球 TC 的发病率显著增加,死亡率下降。SDI 较低、男性和人口老龄化的地区,TC 死亡率没有改善。有效分配资源、细致控制风险因素和制定针对性干预措施对于解决这些问题至关重要。